XML 65 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2022
Apr. 30, 2021
Current Assets    
Cash and cash equivalents $ 4,433 $ 5,206
Restricted cash 2,461 525
Receivables, less allowance: $357 (2022); $636 (2021) 41,254 32,882
Inventories 23,796 16,517
Income tax receivable 0 955
Note receivable 13,457 0
Prepaid expenses and other current assets 6,164 4,372
Total Current Assets 91,565 60,457
Property, plant and equipment, net 15,121 15,982
Right of use assets 7,573 9,279
Other assets 4,514 3,666
Total Assets 118,773 89,384
Current Liabilities    
Short-term borrowings 1,588 6,828
Current portion of financing liability 575 0
Current portion of financing lease liability 126 21
Current portion of operating lease liabilities 1,319 1,348
Accounts payable 27,316 16,780
Employee compensation and amounts withheld 4,504 4,726
Deferred revenue 3,529 3,123
Other accrued expenses 3,336 1,355
Total Current Liabilities 42,293 34,181
Long-term portion of financing liability 28,775 0
Long-term portion of financing lease liability 228 91
Long-term portion of operating lease liabilities 6,179 7,860
Accrued pension and deferred compensation costs 4,159 4,652
Deferred income taxes 428 307
Other non-current liabilities 531 806
Total Liabilities 82,593 47,897
Commitments and Contingencies (Note 9)
Stockholders' Equity    
Common stock 6,983 6,915
Additional paid-in capital 4,483 3,807
Retained earnings 28,023 34,149
Accumulated other comprehensive loss (3,742) (3,577)
Common stock in treasury, at cost: 3 shares (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 35,694 41,241
Non-controlling interest 486 246
Total Stockholders' Equity 36,180 41,487
Total Liabilities and Stockholders' Equity $ 118,773 $ 89,384